PTS Diagnostics Revenue and Competitors
Estimated Revenue & Valuation
- PTS Diagnostics's estimated annual revenue is currently $67M per year.
- PTS Diagnostics's estimated revenue per employee is $155,000
Employee Data
- PTS Diagnostics has 432 Employees.
- PTS Diagnostics grew their employee count by 15% last year.
PTS Diagnostics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $0.8M | 5 | -17% | N/A | N/A |
#2 | $5.7M | 37 | 6% | N/A | N/A |
#3 | $10.2M | 66 | 6% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $2M | 13 | 0% | N/A | N/A |
#6 | $7.6M | 49 | -2% | N/A | N/A |
#7 | $0.8M | 5 | -17% | N/A | N/A |
#8 | $7.9M | 51 | 6% | N/A | N/A |
#9 | $37.7M | 243 | -2% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is PTS Diagnostics?
PTS Diagnostics is an innovative point-of-care diagnostics solutions provider that partners with patients and healthcare professionals to provide the right information at the right time to make the right decisions. The company's name represents the three pillars upon which it has built its long-term success: People, Technology and Service. PTS Diagnostics signature products include the CardioChek® lipid analyzer and the A1CNow® family of products. The CardioChek® family of products have screened more than 120 million patients worldwide while the A1CNow® product line works to enable people to lead healthier lives through ongoing management of diabetes. Together these products help identify individuals with cardiometabolic syndrome, a cluster of conditions that increases the risks of developing cardiovascular disease or diabetes.
keywords:Biotechnology,Hardware,Hardware Peripherals,Healthcare,Medical Devices,Medical Diagnostics
N/A
Total Funding
432
Number of Employees
$67M
Revenue (est)
15%
Employee Growth %
N/A
Valuation
N/A
Accelerator
PTS Diagnostics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Techical Support Specialist | Reveal Email/Phone |
2 | VP Sales, US | Reveal Email/Phone |
3 | Production and Engineering Manager | Reveal Email/Phone |
4 | Account Executive | Reveal Email/Phone |
5 | National Sale Director | Reveal Email/Phone |
6 | Machinist | Reveal Email/Phone |
7 | Sales Director - Latin America & Canada | Reveal Email/Phone |
8 | Senior Director, Quality and Regulatory Affairs | Reveal Email/Phone |
9 | VP Global Marketing | Reveal Email/Phone |
10 | Creative Design Manager | Reveal Email/Phone |
PTS Diagnostics News
Cholesterol Test Kits Consumption Market Size, Share, Forecast 2022-2029| Key Players Alere, Roche, PTS Diagnostics, Beckman Coulter.
... Roche, Bio-Rad, GREEN CROSS MEDIS, Trinity Biotech, HUMAN Diagnostics, Sinocare (PTS Diagnostics), Erba Diagnostics, EKF Diagnostics.
Blood Fat Analyzer Market Set to Witness Explosive Growth by 2029 | PTS Diagnostics, Alere, Acon. Photo of a2z a2zApril 13, 2022. 0 3 minutes read.
Other Companies in Indianapolis
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $177.5M | 433 | 11% | N/A |
#2 | $79.9M | 434 | -1% | $25.1M |
#3 | $181.5M | 440 | 20% | N/A |
#4 | $102.2M | 454 | 4% | N/A |
#5 | $165.3M | 456 | 8% | N/A |
PTS Diagnostics Executives
| Name | Title |
|---|---|
| Stephen Riendeau | Chief Commercial Officer |
| Robert Huffstodt | President & CEO |
| Scott Carpenter | Chief Scientist |
| Steve Riendeau | Chief Commercial Officer |
| Robert Huffstodt | President & CEO |
| Laurie Ellenberger | Sr.Vice President, Accounting and Finance |
| Cliffe Allen | Vice President of Sales, US |
| Will Benedict | VP and General Manager |